Where Will Oklo Stock Be in 3 Years?

Oklo’s stock is described as having fallen nearly 50% from its all-time high of $174.14 to about $77, with the shares still viewed as expensive at roughly 326x estimated 2028 sales. The company has a 14 GW pipeline, including deals with Switch and Equinix, and expects first commercial reactor deployments in 2027, but the article argues the valuation likely outpaces fundamentals. NRC approval and defense-related progress are positives, yet the overall message is cautious to bearish on the stock.

Analysis

The market is still pricing OKLO as if commercialization risk is behind it, when the real risk is the opposite: the asset is only now moving from narrative to execution. That transition typically compresses multiples first, because every delay in licensing, siting, fuel handling, or grid interconnection pushes the revenue curve right while fixed-cost burn continues left. In other words, the stock is effectively a long-duration option on a regulatory schedule, and the current valuation leaves very little room for a 12-24 month slip.

The more interesting second-order effect is on the data-center infrastructure trade. If microreactors become viable, the clearest winners may be the developers and operators of always-on compute capacity, not the reactor vendor itself: EQIX and similar names gain optionality on power independence without taking nuclear execution risk. That creates a cleaner way to express the AI-power theme than owning the pre-revenue nuclear equity, especially because any meaningful OKLO delay would likely not dent near-term AI capex, only shift where the power bottleneck gets monetized.

Consensus seems to be underestimating how hard first deployment is relative to the implied backlog. A signed pipeline has limited value if financing, permits, and operating proof points are not yet bankable; the market will likely re-rate OKLO only after it demonstrates a repeatable path from approval to commissioning, not on additional MOUs. Over the next 6-18 months, the stock is more exposed to disappointment from “good news that is not enough” than to upside from incremental headlines.

The cleaner contrarian view is that the selloff may still not be complete, because the bull case assumes a straight-line conversion of strategic interest into revenue. If the first commercial units slip by even one year, valuation support weakens materially as the 2028 sales base gets pushed out and the price-to-sales anchor remains detached from fundamentals. The asymmetric setup is to fade the install-or-deliver risk, while keeping exposure to the broader power-for-AI theme through higher-quality beneficiaries.

Key Decisions for Investors

• Short OKLO on strength or via put spreads over the next 1-3 months; risk/reward favors downside if commercialization timelines slip, with catalyst sensitivity highest around licensing and deployment updates.
• Pair trade: long EQIX / short OKLO for 6-12 months to capture AI power demand with lower execution risk; EQIX benefits if customers seek power-secure colocation before microreactors are proven.
• Avoid chasing OKLO until first commercial operating milestones are independently validated; require evidence of commissioning progress, not just regulatory or partnership headlines, before revisiting long exposure.
• If expressing a nuclear-power theme, prefer established infrastructure beneficiaries over pre-revenue developers; the market is likely to reward cash-flow visibility more than optionality in the current risk regime.